Public DNA testing: towards a regulated opening in France

In a country where you can compare airline ticket prices in two clicks, but not legally access your own genetic profile, the debate inevitably resurfaces. The citizens' committee of the Estates General on Bioethics, composed of 30 members, recommends authorizing public DNA testing for those who want to know their origins. According to the opinion submitted to the Economic, Social and Environmental Council (CESE), two-thirds of the panel support legalization, provided it is strictly regulated.

France is among the last European countries to maintain the ban, and the ban has its own way of working: it doesn't eliminate demand, it simply shifts it. The French Economic, Social and Environmental Council (CESE) estimates that between 100,000 and 200,000 people living in France turn to foreign companies each year to undergo these tests. Behind these figures, there are often deeply personal, sometimes turbulent, stories of people who were adopted, born anonymously, or conceived through gamete donation, all searching for a name, a connection, a face in their family tree.

The State as arbiter, the market in ambush

The proposed initiative is far from a laissez-faire approach. The citizens' committee has set conditions: samples must be taken at a pharmacy or laboratory for the individuals concerned, data must be stored within the European Union under the guarantees of the GDPR, and a charter must be signed regarding anonymization and control of the shared information. The cost, however, would remain the responsibility of the individual, with no reimbursement, a way of saying that the community is not meant to finance a personal quest, even one that concerns identity.

One clear, unwavering red line remains: there is no question of normalizing over-the-counter medical tests, those kits sold online that promise the moon and the stars regarding health and biological future. The committee recommends maintaining their ban, as much out of caution as realism, because genetic data is not a mere gadget, and a risky interpretation can cause a great deal of uproar within a family, or even in someone's mind.

This is just one step, but it carries weight. The next phase of the national consultations must culminate in a summary from the CCNE in June, followed by an opinion in November, before informing the next bioethics law expected by 2028. Until then, France will have to choose: continue to close the door while allowing French citizens to enter through the digital window, or finally organize controlled access, with clear rules, and accept that parentage, sometimes, is also sought through a digital channel.